A Study of ALN-AAT02 in Healthy Participants and Participants With ZZ Type Alpha-1 Antitrypsin Deficiency Liver Disease
Condition: ZZ Type Alpha-1 Antitrypsin Deficiency Liver Disease Interventions: Drug: ALN-AAT02; Drug: Placebo Sponsor: Alnylam Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials